RRM2 is also regarded as a vital component in tumor progression, a regulator of some oncogenes, and a promising tumor biomarker for many cancers, such as lung adenocarcinoma (14), oral squamous cell carcinoma (15), glioblastoma (16), and breast cancer (17). This evidence concerns the gene RRM2 and breast cancer.